Cargando…

Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review

BACKGROUND: There is increasing concern that prescription stimulants may be associated with adverse cardiovascular events such as stroke, myocardial infarction, and sudden death. Public health concerns are amplified by increasing use of prescription stimulants among adults. METHODS: The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westover, Arthur N, Halm, Ethan A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405448/ https://www.ncbi.nlm.nih.gov/pubmed/22682429 http://dx.doi.org/10.1186/1471-2261-12-41

Ejemplares similares

The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events
por: Galasso, Gennaro, et al.
Publicado: (2010)

Pre-Frailty Increases the Risk of Adverse Events in Older Patients Undergoing Cardiovascular Surgery
por: Rodrigues, Miguel K., et al.
Publicado: (2017)

Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study
por: Wisnivesky, Juan P, et al.
Publicado: (2011)

Identification of an increased lifetime risk of major adverse cardiovascular events in UK Biobank participants with scoliosis
por: Quintero Santofimio, Valentina, et al.
Publicado: (2023)

Testosterone treatment and cardiovascular events in prescription database studies
por: Shores, Molly M
Publicado: (2018)

Effect of Exercise Prescription Implementation Rate on Cardiovascular Events
por: Zhu, Li-Yue, et al.
Publicado: (2022)

Do Clopidogrel Nonresponders Have an Increased Risk of Adverse Events during Supra-Aortal Angioplasty and Stenting?
por: Koerner, Heiko, et al.
Publicado: (2012)

2163 Polypharmacy and patterns of prescription medication use among cancer survivors
por: Murphy, Caitlin, et al.
Publicado: (2018)

Study title: A systematic review of RCTs to examine the risk of adverse cardiovascular events with nicotine use
por: Kim, Mimi M., et al.
Publicado: (2023)

Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis
por: Muñoz-Bravo, Carlos, et al.
Publicado: (2023)

Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis
por: Xia, Ning, et al.
Publicado: (2015)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis
por: Prochaska, Judith J, et al.
Publicado: (2012)

Remnant-Like Particle Cholesterol and the Risk of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Yang, Jie, et al.
Publicado: (2022)

Cannabis and adverse cardiovascular events: A systematic review and meta-analysis of observational studies
por: Theerasuwipakorn, Nonthikorn, et al.
Publicado: (2023)

Antidepressants and cardiovascular adverse events: A narrative review
por: Nezafati, Mohammad Hassan, et al.
Publicado: (2015)

Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome
por: Zhang, Lei, et al.
Publicado: (2022)

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
por: Luo, Lingli, et al.
Publicado: (2023)

Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults
por: Tadrous, Mina, et al.
Publicado: (2021)

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials
por: Rungapiromnan, W., et al.
Publicado: (2017)

Association of uncontrolled blood pressure in apparent treatment‐resistant hypertension with increased risk of major adverse cardiovascular events plus
por: Bakris, George, et al.
Publicado: (2023)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies
por: Armstrong, Ehrin J., et al.
Publicado: (2013)

Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Sterling, Lee H., et al.
Publicado: (2016)

Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis
por: Mincu, Raluca I., et al.
Publicado: (2019)

Comparison of Different Modeling Approaches for Prescription Opioid Use and Its Association With Adverse Events
por: Kurteva, Siyana, et al.
Publicado: (2023)

Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study
por: Liu, Lu, et al.
Publicado: (2022)

Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models
por: Akyea, Ralph K, et al.
Publicado: (2020)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Patients who do not complete cardiac rehabilitation have an increased risk of cardiovascular events during long-term follow-up
por: Sunamura, M., et al.
Publicado: (2020)

Use of prescription medications with cardiovascular adverse effects among older adults in the United States
por: Ozenberger, Katharine, et al.
Publicado: (2022)

Uterine fibroids increase the risk of preterm birth and other adverse birth events: a systematic review and meta-analysis
por: Wang, Xiuling, et al.
Publicado: (2022)

Hypertension, smoking, and preexistence of multiple cardiac risk factors correlate with carfilzomib-induced cardiovascular adverse events in a racially diverse population
por: Doran, Stacey, et al.
Publicado: (2023)

Adverse events of repetitive transcranial magnetic stimulation in older adults with depression, a systematic review of the literature
por: Overvliet, Geke M., et al.
Publicado: (2020)

Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients
por: Zheng, Sean L, et al.
Publicado: (2017)

Prescription Stimulant Misuse Among Nursing Students: A Systematic Review
por: Magnotti, Sebastian, et al.
Publicado: (2023)

Quality of reporting in systematic reviews of adverse events: systematic review
por: Zorzela, Liliane, et al.
Publicado: (2014)

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
por: Yu, Yue, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_73ct2267t9310ncurn0hc7nfkj